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Abstract
The study evaluated effects of hyposmotic shock on the rate of Rb+/K+ efflux, intracellular pH and energetics in Langendorff-perfused rat
hearts with the help of 87Rb- and 31P-NMR. Two models of hyposmotic shock were compared: (1) normosmotic hearts perfused with low
[NaCl] (70 mM) buffer, (2) hyperosmotic hearts equilibrated with additional methyl a-D-glucopyranoside (Me-GPD, 90 or 33 mM) or urea
(90 mM) perfused with normosmotic buffer. Four minutes after hyposmotic shock, Rb+ efflux rate constant transiently increased
approximately two-fold, while pH transiently decreased by 0.08 and 0.06 units, in the first and the second models, respectively, without
significant changes in phosphocreatine and ATP. Hyposmotic shock (second model) did not change the rate of Rb+/K+ uptake, indicating that
the activity of Na+/K+ ATPase was not affected. Dimethylamiloride (DMA) (10 AM) abolished activation of the Rb+/K+ efflux in the second
model; however, Na+/H+ exchanger was not involved, because intracellular acidosis induced by the hyposmotic shock was not enhanced by
DMA treatment. After 12 or 20 min of global ischemia, the rate of Rb+/K+ efflux increased by 120%. Inhibitor of the ATP-sensitive
potassium channels, glibenclamide (5 AM), partially (40%) decreased the rate constant; however, reperfusion with hyperosmolar buffer (90
mM Me-GPD) did not. We concluded that the shock-induced stimulation of Rb+/K+ efflux occurred, at least partially, through the DMA-
sensitive cation/H+ exchanger and swelling-induced mechanisms did not considerably contribute to the ischemia–reperfusion-induced
activation of Rb+/K+ efflux.
Crown Copyright D 2002 Published by Elsevier Science B.V. All rights reserved.
Keywords: Osmotic shock; Ischemia; Cation/H+ exchanger; Intracellular pH; Rb+/K+ flux
1. Introduction
Accumulation of end-products of ischemic metabolism in
cardiomyocytes results in osmotic swelling, which may
contribute towards the K+ loss induced by ischemia–reper-
fusion and aggravate ischemic assault [1–5]. Osmotic
swelling activates ion transport in a variety of cell types
[6–8]. In cardiomyocytes, ion transport involved in volume
regulation has been almost exclusively studied at the level
of isolated cells [9,10]. However, at this level, it is impos-
sible to consider all the effects of ischemia–reperfusion that
occur in a beating heart and accurately evaluate possible
contribution of ischemia-induced swelling to the K+ efflux.
Several transmembrane ion transporters are involved in
mammalian cardiomyocyte osmotic swelling and regulatory
volume decrease, including the K+/Na+/2Cl and K+/Cl
co-transporters, and the Cl/HCO3
 and Na+/H+ exchangers
[4,5,12]. A nonselective amiloride-sensitive cation/H+ anti-
porter was identified in sarcolemmal vesicles from bovine
hearts [13,14]. Recently, we reported that intracellular
alkalosis (0.2 units) caused a two-fold activation of the
Rb+ efflux from perfused rat hearts [15]. This also implies
activation of a cation/H+ exchanger or a cation/OH co-
transporter. A different, electrogenic, type of K+ transporter,
ATP-sensitive K+(KATP) channel, is present in the cardiac
sarcolemma [16]. Activated by a decrease in ATP/ADP
ratio, this channel accounts for a significant fraction
(although not all) of the K+ loss during ischemia [1];
however, the channel’s role in osmoregulation is not clear.
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87Rb-NMR is a very sensitive method that has been
successfully used for in situ studies of K+ homeostasis in
normal and metabolically challenged rat hearts as well as
ischemic and hypoxic swine hearts [15,17–22]. Rb+ is the
closest K+ congener replacing it in all known biochemical
processes, catalyzed by Na+/K+ ATPase, the K+/Na+/2Cl
co-transporter, and K+ channels [15,17–25]. 87Rb has
f 28% natural abundance and absolute NMR-sensitivity
100 times higher than 39K. The present experiments were
designed to evaluate the effects of hyposmotic shock on
unidirectional Rb+/K+ effluxes in Langendorff-perfused rat
hearts and to test the hypothesis regarding the role of
ischemia-induced swelling in the K+ loss during reperfu-
sion. In addition, involvement of K+ channels/transporters in
the swelling-induced stimulation of the Rb+/K+ efflux and
the effects on pHi and phosphorus metabolites were exam-
ined using 87Rb- and 31P-NMR spectroscopy.
2. Materials and methods
The investigation conforms with the ‘‘Guide to the Care
and Use of Experimental Animals’’ published by the Cana-
dian Council on Animal Care (2nd ed., Ottawa, ON, 1993).
2.1. Chemicals and reagents
Dimethylamiloride (DMA) was purchased from Research
Biochemicals International (Natick, MA). Bumetanide
(Bum), dimethylsulfoxide (DMSO), glibenclamide (Glib),
2-deoxy-D-glucose (2-DG), methyl a-D-glucopyranoside
(Me-GPD), and RbCl were purchased from Sigma (St.
Louis, MO). Dinitrostilbene-2,2V-disulfonic acid (DNDS)
was supplied by the Molecular Probes (Eugene, OR). All
other chemicals were of analytical grade.
2.2. Solutions
Stock solutions of Glib and Bum were prepared in
DMSO and further diluted in slightly alkaline water to give
final concentrations of Glib, 5 AM; Bum, 10 AM; and
DMSO, 0.08% (vol./vol.). DNDS and DMA were used as
aqueous solutions at final concentrations of 100 and 10 AM,
respectively.
2.3. Perfusion buffers
Basic phosphate-free Krebs–Henseleit buffer (KHB, 315
mOsm) contained (in mM): 25 NaHCO3, 118 NaCl, 4.7
KCl, 1.75 CaCl2, 1.2 MgSO4, 0.5 EDTA, and 11 glucose.
Composition of KHB-Rb was identical to that of KHB,
except for the K+ substitution with Rb+ by 50%. Hypo-
smotic buffer (219 mOsm) contained (in mM): 25 NaHCO3,
70 NaCl, 4.7 KCl, 0.6 CaCl2, 1.2 MgSO4, 0.5 EDTA, and
11 glucose. [CaCl2] in the hyposmotic buffer was reduced to
prevent intracellular calcium excess, because under condi-
tions of low extracellular [Na+], the mode of action of the
Na+/Ca2 + exchanger is shifted towards Ca2 + entry being
more favorable [26]. The reduction in CaCl2 concentration
to 0.6 mM was calculated based on cubic dependency of
Na+–Ca2 + exchange and EDTA concentration. Composi-
tion of modified normosmotic low-Na+/Cl/Ca2 +buffer
(315 mOsm) was identical to that of the hyposmotic buffer
except for the addition of 96 mM mannitol. In case of a
hyperosmotic perfusion buffer, Me-GPD (33 or 90 mM) or
urea (90 mM) was added through the infusion line to KHB
or KHB-Rb.
2.4. Heart perfusion
Male Sprague–Dawley rats (320–400 g, n = 97) were
anesthetized with pentobarbital sodium (120 mg/kg). The
hearts (1.4–1.7 g) were quickly removed and perfused with
KHB through the aorta at a constant flow of 13–15 ml/min.
The buffer was aerated with a mixture of 95% O2 and 5%
CO2 to keep pO2 at approximately 600 mm Hg and pH at
7.4 at 36 jC. The water-filled balloon inserted into the left
ventricle was connected to a Statham P23Db pressure
transducer and to a Digi-Med Model-210 heart performance
analyzer (Micro-Med, Louisville, KY) to monitor heart rate
(HR), left ventricular systolic (LVSP), and left ventricular
end-diastolic (LVEDP) pressure. The pressure-rate product
(PRP), calculated as the product of developed pressure
(LVSP minus LVEDP) and the HR, was used as an index
of mechanical work. The coronary flow rate was monitored
using an ultrasonic blood flow meter (Transonic Systems
Inc., Ithaca, NY), and perfusion pressure was measured
through the catheter connecting the aortic line and the 2nd
pressure transducer. During initial experiments, the heart
temperature was monitored constantly by placing a copper-
constantan thermocouple (Omega Engineering, Stamford,
CT) in the right ventricle. After the setup parameters were
established, the thermocouple was not used to avoid the
noise picked up by the wires.
2.5. Experimental protocols
2.5.1. 87Rb-NMR protocols
The hearts were loaded with Rb+ for 30 min (Fig. 1A–
E). Rb+ washout was initiated by changing perfusion to a
Rb+-free buffer. The data on the initial Rb+ washout mostly
reflected the extracellular Rb+ efflux and were discarded
(first 4 or 6 min of the washout, as indicated, being the same
within each group). Control: protocol A, following the Rb+-
loading period, the hearts were perfused with KHB (Fig.
1A). In protocol B, following the washout of the extrac-
ellular Rb+, the perfusion changed from normosmotic to
hyposmotic (the first model of hyposmotic shock) or nor-
mosmotic low-Na+/Cl/Ca2 + buffer containing 96 mM
mannitol (Fig. 1B). Glib (5 AM), Bum (10 AM), or DMA
(10 AM) were infused simultaneously with the transition to
hyposmotic KHB (Fig. 1B). In protocol C, the intracellular
O. Jilkina et al. / Biochimica et Biophysica Acta 1637 (2003) 20–30 21
osmolarity of the hearts increased via isosmotic uptake of
Me-GPD (33 or 90 mM) or urea (90 mM) from the hyper-
osmotic perfusion buffer (Fig. 1C). The perfusion changed
from hyperosmotic to normosmotic (the second model of
hyposmotic shock), following the washout of the extracel-
lular Rb+ (Fig. 1C). Drug infusion (5 AM Glib, 10 AM Bum,
10 AM DMA, or 100 AM DNDS) started 16 min prior to the
hyposmotic shock and lasted 28 min (Fig. 1C). In protocol
D, the effect of hyposmotic shock on the Rb+ uptake rate
was measured. Prior to the Rb+ loading, the hearts were
made hyperosmotic by perfusion with the hyperosmotic
buffer (Fig. 1D). Simultaneously with the start of Rb+
loading, the perfusion changed to normosmotic KHB-Rb
(Fig. 1D). In protocol E, the effect of global ischemia on the
rate of Rb+ efflux was measured. Following the washout of
extracellular Rb+, the perfusate flow stopped (Fig. 1E). The
temperature of the hearts during ischemia was maintained at
36 jC. Reperfusion was performed in the presence of no
drugs, 5 AM Glib or 90 mM Me-GPD.
2.5.2. 31P-NMR protocols
After cardiac function stabilization, three initial 4-min
31P spectra were acquired and used as baseline (Fig. 1F,G).
In control group, 20 mM HEPES, pH 7.4 was infused for
48 min to a final concentration of 0.3 mM. In protocol 1F,
the effect of a transition from normosmotic to hyposmotic
or normosmotic low-Na+/Cl/Ca2 + perfusion was studied
(Fig. 1F). 2-DG (10 mM) was infused for 8 min to provide
an additional probe for the pHi measurements (2-DG-6-
phosphate peak), followed by 8-min DG washout period,
after which the perfusion was switched to either hypo-
smotic KHB or normosmotic low-Na+/Cl/Ca2 + buffer
(containing 96 mM mannitol) (Fig. 1F). After 20 min of
the perfusion with the modified buffers, the perfusion
returned to the basic KHB. In protocol G, the effects of
a transition from hyperosmotic to normosmotic perfusion
were studied. With this purpose, 33 mM Me-GPD was
infused for 24 min, followed by 24-min perfusion with
basic KHB (Fig. 1G).
Fig. 1. Schematic representation of 87Rb- and 31P-NMR experimental protocols. 87Rb-NMR protocols (A–E). Protocol A describes control experiments.
Protocol B describes perfusion with the hyposmotic KHB in the presence or absence of mannitol (Mann) or K+ transport inhibitors. Protocol C describes
experiments with Me-GPD or urea added before Rb+-washout step. Protocol D describes experiments with Me-GPD added to KHB prior to the Rb+ loading.
Protocol E describes experiments with ischemia. 31P-NMR protocols (F,G). The hearts were perfused with KHB for 12 min to acquire the baseline spectra.
Protocol F describes experiments with the hyposmotic KHB in the presence or absence of mannitol (Mann). 2-DG was added before transition to a low low-
Na+/Cl/Ca2 + buffer. Protocol G describes experiments with Me-GPD infusion. The exact composition of perfusion buffers and concentration of drugs are
described in Materials and methods.
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2.6. NMR spectroscopy
NMR experiments were carried out using a Bruker AM-
360 WB spectrometer equipped with a 20 mm Morris
Instruments broadband probe placed in a wide bore vertical
8.4 T magnet. The 23Na signal (95.25 MHz) from the heart
and surrounding bath was used for adjusting the homoge-
neity (shimming) of the magnetic field. 87Rb NMR spectra
were acquired at 117.8 MHz every 2 min using a spectral
sweep width of 18 kHz, a recycle time of 10 ms, and pulse
duration of 55 As (90j flip angle). Memory size was 512
data points. Before Fourier transformation, exponential
multiplication with a line-broadening factor of 150 Hz
was applied to the 87Rb-NMR data. Baseline correction
and peak amplitude measurements were done using 1D
WINNMR computer program. To minimize the signal from
extracardiac 87Rb, the hearts were perfused in a ‘‘dry mode’’
by placing a suction line at the bottom of the NMR tube. A
10-Al capillary containing 1 M RbCl and 5 M KI was used
as a reference.
31P-NMR spectra were acquired at 145.8 MHz using a
24-As pulse length (60j flip angle), 2.0 s recycle time
(partially saturated) and 4 min resolution time. The sweep
width was 10 kHz, memory size, 4 K data points, and line
broadening factor, 20 Hz. After baseline correction (spline),
the heights and chemical shifts of the peaks of inorganic
phosphate (Pi), phosphocreatine (PCr), and h- and g-phos-
phates of ATP were measured. A 10-Al capillary containing
of 1 M solution of phenylphosphonic acid was used as a
reference.
2.7. Measurements of pHi
Changes in pHi were estimated from the chemical shift of
Pi and 2-DG resonances relative to that of PCr, using
calibration curves obtained earlier [27].
2.8. Rate constants
First-order rate constants for Rb+ efflux (k, min 1) were
calculated as follows. Natural logarithms of Rb+ peak
intensity were plotted as a function of time (see Figs. 2, 3
and 7). After time points reflecting extracellular Rb+ wash-
out were discarded, the rest of the data were subjected to the
linear regression analysis and k was calculated as a slope of
a straight line (see Figs. 2, 3 and 7). In the 87Rb-NMR
experiments on the effects of hyposmotic shock and ische-
mia, only linear parts of the experimental curves were used
for calculations of k because activation of the Rb+ efflux
developed in time.
2.9. Data analysis and statistics
Data are presented as meansF S.E. (standard errors). A
two-tailed paired Student’s t-test was used for comparisons
within groups (pHi changes), and one-factor ANOVA was
used for comparisons between groups at a significance level
of 95%.
3. Results
3.1. Activation of the Rb+ efflux by transition to hyposmotic
perfusion
Perfusion of Rb+-loaded rat hearts with basic KHB (315
mOsm) resulted in a passive Rb+ efflux through the sarco-
lemma of myocytes [18]. Kinetics of the basal Rb+ efflux
appeared mono-exponential (Fig. 2), the mean Rb+ efflux
rate constant was 0.040F 0.001 min 1, (Table 1) and did
not change over the time-course of the experiments. To
evaluate the effects of hyposmotic shock, composition of the
Fig. 2. Rb+ efflux from normosmotic rat hearts perfused with a hyposmotic
buffer. (A) Representative 87Rb-NMR spectra illustrating Rb+ efflux from a
perfused heart under control (top) and hyposmotic conditions (bottom). Rb+
washout was initiated at time = 0. Spectra at time 0 and 2 min are not
shown. (B) Time course of the Rb+ efflux activated by a hyposmotic
perfusion (first model of hyposmotic shock). Data are presented as
semilogarithmic plots and straight lines are linear fits to data for control
hearts (starting from 8-min Rb+ washout) and for hyposmotically treated
hearts (between 10 and 16 min). MeansF S.E. (standard errors) are
presented.
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perfusion buffer was changed to hyposmotic: concentration
of [NaCl] was decreased from 118 to 70 mM, as described
previously in the isolated cardiomyocytes studies, thus
reducing osmolarity of the perfusion buffer from 315 to
219 mOsm [9,10]. However, in a rat heart, even a moderate
decrease in extracellular [Na+] results in the increased Ca2 +
entry into the cells [26]. To prevent Ca2 + overload through
the Na+/Ca2 + exchanger, total Ca2 + concentration was
reduced to 0.6 mM (see Materials and methods). Transition
to the hyposmotic buffer (protocol B, Fig. 1B) resulted in a
marked stimulation of the Rb+ efflux (Fig. 2). Approxi-
mately 4 min after hyposmotic shock, Rb+ efflux rate
constant reached a maximum of 0.070F 0.007, min 1
(Fig. 2, Table 1). A peak response of the Rb+ efflux was
observed for an approximately 6-min period; however, the
efflux rate remained elevated until the end of the experi-
ments (Fig. 2). It is worth noting that the line width of the
cardiac Rb+ peaks was not affected by the osmolarity
change in our experiments (Figs. 2A); therefore, an approx-
imation of the Rb+ signal by referring to the Rb+-NMR
spectra amplitude was accurate.
The decrease in [Ca2 +] resulted in a diminished cardiac
function (see cardiac function further). Therefore, the appro-
priate control for the hearts perfused with the hyposmotic
buffer was perfusion with a low-Na+/Cl/Ca2 + normosmotic
perfusion buffer (315 mOsm due to an addition of 96 mM
mannitol). Perfusion with the normosmotic low-Na+/Cl/
Ca2 + buffer abolished the activation: k = 0.033F 0.003
min 1 (Table 1), confirming that stimulation of the Rb+
efflux was caused by a decrease in osmolarity rather than by
a change in the ion composition. The hyposmotic activation
of the Rb+/K+ efflux relative to the normosmotic low-Na+/
Cl/Ca2 + perfusion was more than 100%.
3.2. Activation of the Rb+ efflux by transition from
hyperosmotic to normosmotic perfusion
To exclude the effects of manipulations with the perfu-
sion buffer ion composition and examine the effect of
hyposmotic shock under normal physiological conditions
when the heart’s contractile function was maintained at the
baseline level (see cardiac function further), a different
model was developed. A non-metabolizable glucose analog,
Me-GPD, which is taken up by rat myocytes via glucose
transporters [28], was added to the perfusate during the Rb+-
loading stage. This resulted in an increase in the heart’s
intracellular osmolarity due to isosmotic uptake of Me-
GPD. In this model, hyposmotic shock was achieved by
changing the perfusion to the basic KHB during Rb+-
washout stage of the protocol (Fig. 1C). Approximately 4
min after the shock, the Rb+ efflux rate constant increased
transiently to 0.067F 0.010 min 1 (Fig. 3, Table 1). Tra-
num-Jensen et al. [3] found that the actual increase in the
tissue osmolarity was only 40 mOsm/kg after 60-min
ischemia. Thus, to examine the situation similar to the real
one, we evaluated the effect of 33 mM Me-GPD-loading. In
this setup, the Rb+ efflux rate also increased transiently to
0.063F 0.007 min 1 (Table 1). Similar results were
obtained when the intracellular osmolarity of the hearts
increased via isosmotic uptake of 90 mM urea: the Rb+
efflux rate constant transiently increased to 0.061F 0.007
min 1 (Table 1).
3.3. Contributions of K+ channels/transporters to hypo-
smotically sensitive Rb+/K+ effluxes
Specific inhibitors of individual ion transport systems
were used to examine the contribution of each of these
systems to the observed stimulation of the Rb+ efflux.
Quantitative analysis was limited due to very fast changes
in the hyposmotically sensitive component of the efflux
and time requirements for the reliable signal-to-noise
spectral characteristics. Therefore, contributions of the
specific cation transporters in swelling-induced Rb+/K+
efflux were not additive. The inhibitor concentrations for
the K+/Na+/2Cl co-transporter (Bum, 10 AM), KATP
channels (Glib, 5 AM), Na+/H+ exchanger (DMA, 10
AM), and Cl/HCO3 exchanger (DNDS, 100 AM) were
within the range used for cardiomyocytes [9–15,17–
20,27,29]. We have shown previously that at the indicated,
or higher, concentrations, Bum [18], Glib [29], DMA [17],
and DNDS [15] do not affect the basal Rb+ efflux. In the
first model, none of the inhibitors abolished the activation
of the Rb+ efflux. In the second model, Bum and DNDS
Table 1
Effects of hyposmotic shock and cation transporter inhibitors on the Rb+
efflux rate constant
Group k (min 1), meanF S.E.
(1) Control, n= 3 0.040F 0.001
(2) Normosmotic perfusion,
low Na+/K+/Cl+ +mannitol,
n= 3
0.033F 0.003
Hyposmotic perfusion
(3) No drugs, n= 8 0.070F 0.007 ( P < 0.02 vs. control)
(4) +Bum, n= 4 0.067F 0.003 (NS vs. group 3)
(5) +Glib, n= 6 0.058F 0.005 (NS vs. group 3)
(6) +DMA, n= 6 0.058F 0.003 (NS vs. group 3)
Hyperosmotic hearts
(7) 90 mM Me-GPD, n= 3 0.067F 0.010 ( P < 0.04 vs. control)
(8) 90 mM urea, n= 3 0.061F 0.008 ( P < 0.05 vs. control)
(9) 33 mM Me-GPD, n= 3 0.063F 0.007 ( P < 0.04 vs. control)
(10) 33 mM Me-GPD+Bum,
n= 5
0.042F 0.006 ( P < 0.04 vs. group 9)
(11) 33 mM Me-GPD+Glib,
n= 4
0.047F 0.005 (NS vs. group 9)
(12) 33 mM Me-GPD+DMA,
n= 4
0.035F 0.007 ( P < 0.03 vs. group 9)
(13) 33 mM Me-GPD+DNDS,
n= 4
0.044F 0.004 ( P < 0.04 vs. group 9)
Drugs (10 AM Bum, 5 AM Glib, 10 AM DMA, and 100 AM DNDS) were
added as described in Materials and methods (see 87Rb-NMR experimental
protocols). NS, statistically not significant using the same time intervals for
the respective groups.
O. Jilkina et al. / Biochimica et Biophysica Acta 1637 (2003) 20–3024
had some inhibiting effects, and DMA completely blocked
the activation (Table 1).
3.4. Effect of hyposmotic shock on the Rb+ influx
In the so far described results, we measured increases in
unidirectional Rb+ effluxes, which do not necessarily reflect
activation of the net Rb+ efflux, since this is a difference
between the unidirectional efflux and uptake. For this
reason, the effect of hyposmotic shock on the Rb+/K+
uptake, which is mainly determined by the Na+/K+ ATPase,
was also investigated. The hearts were made hyperosmotic
and then perfused with a normosmotic KHB-Rb (protocol
D, Fig 1D). The results showed that the hyposmotic shock
(second model) did not change the initial rate of the Rb+
accumulation at the scale of time-resolution in our experi-
ments (2–4 min) (Fig. 4).
3.5. Effects of hyposmotic shock on high-energy phosphates
and intracellular pH
To measure pHi during perfusion with low-Na
+/Cl/
Ca2 + buffers, when the Pi peak was undetectable due to
low contractile activity of the hearts (see cardiac function
further), 2-DG (10 mM) was infused briefly (8 min). Under
the conditions, when phosphate pool is limited (phosphate-
free perfusion buffer), 2-DG is known to reduce the PCr and
ATP contents of the hearts due to synthesis of 2-DG-6-
phosphate [27]. Accordingly, following 2-DG treatment, the
PCr fell to approximately 60% and then returned to the
baseline (Table 2). Hyposmotic treatment did not affect PCr,
compared to its level before 2-DG infusion (Table 2).
Fig. 3. Time course of the Rb+ efflux activated by a transition from hyperosmotic to normosmotic perfusion (second model of hyposmotic shock). Rb+ washout
was initiated at time = 0. The hearts were made hyperosmotic via Me-GPD uptake from the hyperosmotic perfusate (containing 90 mM Me-GPD) during Rb+
loading (protocol C, Fig. 1C). Following washout of extracellular Rb+ (first 6 min), perfusion changed to normosmotic by stopping infusion of Me-GPD to
KHB. Data are presented as semilogarithmic plots and straight lines are linear fits to data for control hearts (starting from 8-min Rb+ washout) and for
hyperosmotic hearts (between 12 and 16 min). MeansF S.E. are presented.
Fig. 4. The effect of hyposmotic shock on the rate of the Rb+ uptake. The
hearts were made hyperosmotic by perfusion with the hyperosmotic buffer
(KHB+ 90 mM Me-GPD) for 20 min prior to the Rb+ loading (protocol D,
Fig. 1D). The osmolarity of the perfusate returned to normal by stopping
Me-GPD infusion, which resulted in hyposmotic shock at time = 0,
simultaneously with the start of Rb+ loading (n= 4). In control experiments
(n= 3), the hearts were perfused with the regular KHB prior to the Rb+
loading. The data corresponding to the first 2 min of the Rb+ accumulation
reflected mostly extracardiac and extracellular Rb+ accumulation and were
discarded. MeansF S.E. are presented.
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Following 2-DG-pulse and hyposmotic treatment, the ATP
level remained high: approximately 90% (Table 2).
Transition to a hyposmotic perfusion resulted in a tran-
sient, slight, but statistically significant acidosis of the
cardiomyocyte cytosol: DpHi = 0.08F 0.03 units, P <
0.03 (Fig. 5). In comparison, no decrease in pHi was
observed when the osmolarity of the perfusion buffer was
restored by the addition of 96 mM mannitol (Fig. 5). In
agreement with our previous observation [27], following 2-
DG-treatment, pHi decreased from 7.14F 0.01 to 7.01F
0.03 (n = 9, the two groups, ‘‘hyposmotic’’ and ‘‘hyposmo-
tic +mannitol’’, together). A slow increase in pHi observed
in both groups upon switching to low-Na+/Cl/Ca2 + perfu-
sion (Fig 5) was likely due to the return of pHi to the baseline
after 2-DG washout.
In the second model of hyposmotic shock, Me-GPD
loading and its subsequent washout did not affect PCr
and ATP (Table 2). Increasing intracellular osmolarity
with 33 mM Me-GPD did not significantly change pHi.
However, when perfusion changed to normosmotic, pHi
decreased transiently by 0.06F 0.02 units (P < 0.006,
Fig. 6). If the Na+/H+ exchanger were activated by the
shock, its inhibition by DMA would have reduced
proton efflux and, thereby, enhanced intracellular acido-
sis. Contrary to the expectation, this was not observed
(Fig. 6). Fig. 6 demonstrates that DNDS that inhibits
HCO3
 influx (equivalent to H+ efflux) through the
HCO3
/Cl antiporter prolonged swelling-induced acido-
sis (P= 0.05).
3.6. Effect of hyperosmotic reperfusion on Rb+ efflux
stimulated by ischemia
We analyzed the effects of reperfusion buffer osmolarity
on the rate of the Rb+ efflux from ischemic rat hearts. We
hypothesized that higher osmolarity of reperfusion buffer
may reduce hyposmotic shock after ischemia–reperfusion
and reduce the Rb+ efflux. To test this hypothesis, the hearts
were subjected to 20-min global ischemia and reperfused
under different conditions. In control group, on reperfusion,
the Rb+ efflux rate constant transiently increased by more
than 120%, from 0.040F 0.001 to 0.089F 0.004 min 1
(Fig. 7). The activation lasted up to 6 min, followed by the
return of the Rb+ efflux to the basal level (Fig. 7). Glib
inhibited the stimulation by approximately 40%: k = 0.070F
0.0065 min 1, P < 0.05 (Fig. 7). However, hyperosmotic
reperfusion (basic KHB+ 90 mM Me-GPD) did not prevent
the activation. Instead, we found that the efflux rate constant
increased to 0.12F 0.015 min 1, P < 0.05 (Fig. 7). Similar
results were obtained when Me-GPD was added to the buffer
before ischemia and reperfusion (not shown). Similarly, 12-
min global ischemia increased the Rb+ efflux rate constant
by 120%: k = 0.087F0.010 min 1, n= 4. Representative
experiments demonstrated that this increase was also
sensitive to Glib (k = 0.066F 0.002 min 1, n = 2), but
was not, however, prevented by the addition of mannitol
(50 mM) on reperfusion (k = 0.102F 0.001 min 1, n = 2).
Table 2
Effects of hyposmotic shock on PCr and ATP
Parameter Conditions
(% of initial)
Control, n= 5,
48-min infusion
Transition from normosmotic to
hyposmotic perfusion, n= 5
Transition from hyperosmotic to
normosmotic perfusion, n= 7
of HEPES
8-min infusion
of 2-DG
20-min of
hyposmotic KHB
24-min infusion
of Me-GPD
24-min following
termination of
Me-GPD infusion
PCr (%) 87.8F 2.3 61.2F 2.1* 92.0F 4.7 93.6F 3.2 87.3F 3.1
ATP (%) 91.4F 2.5 96.F 4.3 83.8F 3.5 99.2F 5.5 92.0F 5.1
PCr and ATP levels before interventions were set as 100%.
* Statistically significant vs. control.
Fig. 5. The effect hyposmotic perfusion on changes in pHi. After
acquisition of three baseline 31P spectra, 10 mM 2-DG was infused for 8
min (protocol F, Fig. 1F). Following 8 min of 2-DG washout, the perfusion
changed either to hyposmotic (n= 5) or normosmotic low-Na+/Cl/Ca2 +
KHB (n= 4) containing 96 mM mannitol. After 20-min perfusion with the
modified buffers, the perfusion returned to basic KHB. The exact
composition of the perfusion buffers is described in Materials and methods.
MeansF S.E. are presented. Two-tailed paired Student’s t-test was used for
data comparisons: pHi before and after hyposmotic shock for the same heart
was compared. *Significantly different vs. previous state (at time = 0).
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3.7. Effects of hyposmotic shock and ischemia on cardiac
function
PRP, used as a cardiac function index, was taken as
100% prior to the Rb+ loading. In agreement with our
previous observations [15,17–20], Rb+ loading slightly
decreased HR: 50% Rb+ substitution depressed HR by
10–15%; however, developed pressure simultaneously
increased by approximately the same degree and, on aver-
age, PRP did not change significantly (not shown). Perfu-
sion with the hyposmotic buffer resulted in a decrease in
PRP to less than 10% of the baseline, which was mainly due
to a drop in the left ventricular developed pressure and a
decrease in HR (Table 3). The observed changes were most
likely caused by a reduction of [Ca2 +] in the perfusate and
were reversed on return to KHB (not shown). In the post-
hyperosmotic (addition of 33 mM Me-GPD) group, all the
parameters did not differ significantly from the control
group (Table 3).
In the ischemic experiments, on stopping the coronary
flow, cardiac contractile function immediately declined and
stopped within 4–6 min. The contractile function of the
hearts subjected to the 20-min ischemia recovered to about
10% by 20-min reperfusion. In all hearts subjected to the
12-min ischemia, the HR returned to preischemic values on
reperfusion, PRP recovered to 57F 8% of the baseline by 8-
min reperfusion, and to 86F 11% by 20-min post-ischemia.
Fig. 6. The effect of normosmotic perfusion of hyperosmotic hearts on pHi. After acquisition of three baseline
31P spectra (time = 0), perfusion changed to
hyperosmotic buffer (KHB+33 mM Me-GPD, n= 7) for 24 min, followed by the return to basic KHB. Infusion of DMA (10 AM, n= 6) or DNDS (100 AM,
n= 6) started 12 min before the hyposmotic shock and continued for additional 16 min after the shock. The exact composition of the perfusion buffers is
described in Materials and methods. MeansF S.E. are presented. Two-tailed paired Student’s t-test was used for data comparisons: pHi before and after
hyposmotic shock for the same heart was compared. *Significantly different vs. previous state (at time = 24).
Fig. 7. The effects of Glib and perfusate osmolarity on the ischemia–
reperfusion-induced Rb+ efflux. The experiments were performed as
described in Materials and methods (protocol 1E, Fig. 1E). Reperfusion
was initiated at time = 0 in the presence of no drugs (n= 3), 5 AM Glib
(n= 3), or 90 mM Me-GPD (n= 4). MeansF S.E. are presented. Data are
presented as semilogarithmic plots and straight lines are linear fits to time
points between 0 and 6 min. Rb+ leaving the hearts at time ‘‘zero’’ was
present in the intracellular space of the hearts at the time ischemia was
initiated (see Materials and methods, 87Rb-NMR experimental protocols,
protocol E, Fig. 1E).
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Addition of mannitol, Me-GPD, Glib, Bum, and DMA at
the indicated concentrations did not significantly alter car-
diac function vs. respective groups that had no such addi-
tions (not shown).
4. Discussion
4.1. Effect of hyposmotic shock on Rb+/K+ efflux and uptake
We demonstrated approximately two-fold transient stim-
ulation of the unidirectional Rb+/K+ efflux rate by hypo-
smotic shock, in isolated beating rat hearts. The shock was
induced by the hearts exposure to low [NaCl] buffer, or,
alternatively, by loading the hearts with Me-GPD and urea,
followed by perfusion with the normosmotic buffer. The
degree of the Rb+/K+ efflux stimulation was higher and it
lasted longer in the first model. This probably reflects the
differences between the two models. A decrease in the Ca2 +
concentration in the first model may have added to the
activation of the efflux. In support of this possibility, in
bovine vascular endothelial cells, swelling-activated Rb+/K+
efflux occurs through Ca2 +-dependent and independent
mechanisms [30]. The increase in the Rb+/K+ efflux was
delayed by several minutes in all our experimental setups,
most likely reflecting the phase of regulatory volume
decrease that follows hyposmotic swelling. Such depend-
ence is in agreement with isolated cardiomyocyte studies,
where changes in cell shape were observed after approx-
imately 30 s of hyposmotic challenge, while regulatory
volume decrease occurred only after several minutes
[10,11]. Similarly, volume-activated Rb+/K+ efflux from
lactating rat mammary tissue reached peak response 4 min
after the expose to hyposmotic buffer [31] and full activa-
tion of the Rb+/K+ efflux in swollen endothelial cells
required 2 min [30].
Role of Na+/K+ ATPase in the cardiomyocyte volume
and cation transport regulation in response to short-term
hyposmotic exposure is controversial, as different groups
reported different results. Inhibition of the pump reduced
rabbit cardiomyocyte swelling caused by hyposmotic sol-
ution but it had no effect under normosmotic conditions [9].
In newborn rat cardiomyocytes, inhibition of the pump had
no significant effect on the cell volume, suggesting the role
for other compensatory transport mechanisms [10]. How-
ever, osmotic swelling activated Na+/K+ ATPase in rabbit
cardiomyocytes, whereas shrinkage inhibited the pump, as
assessed electrophysiologically [11]. We found no effect of
hyposmotic shock (second model) on the rate of Rb+/K+
influx under physiological ion concentrations and contrac-
tile activity of rat hearts at the baseline level. This may be
due to different parameters assayed: membrane currents vs.
rate of Rb+ accumulation; and different models: patch-
clamped rabbit cells vs. intact rat hearts [11].
4.2. Inhibitory analysis
Unlike addition of mannitol, none of the inhibitors at the
indicated concentrations were able to significantly affect the
Rb+/K+ efflux activation in the first model of the hypo-
smotic shock. This implies that none of the ion transport
systems affected by the inhibitors were solely responsible
for the shock-activated Rb+ efflux. Evidence for a possible
role of KATP channels in the swelling-activated K
+ current
was presented by Priebe and Beuckelmann [32] in guinea-
pig ventricular myocytes. In the above study, 1 AM Glib
abolished the shortening of the action potential induced by
hypotonic swelling [32]. In our study, 5 AM Glib, which is
sufficient to block metabolically activated Rb+ efflux from a
rat heart [18,19,29], did not significantly affect the activa-
tion of the Rb+/K+ efflux by osmotic shock. The differences
are most probably related to the involvement of electro-
neutral transporters in the swelling-activated Rb+/K+ efflux,
such as the K+/Na+/2Cl and K+/Cl co-transporters and the
nonselective cation/H+ exchanger in the response to the
shock [4,5,12]. The effects of blockade of other swelling-
activated K+ currents with protein tyrosine kinase inhibitors
such as genestein could not be tested due to the existence of
multiple targets of genestein in whole hearts [33]. The role
for the Na+-sensitive K+ currents in the rat heart has not
been demonstrated [34].
Bum decreased the Rb+/K+ efflux in the second model of
hyposmotic shock. In this regard, Bum-sensitive K+/Na+/
2Cl co-transporter has been previously implicated in the
Table 3
Effects of change in osmolarity of the perfusion buffer on cardiac function
Group Baseline Treatment
HR (beats/min) Developed pressure
(mm Hg)
HR (beats/min) Developed pressure
(mm Hg)
PRP (%)
Control (Rb+-protocol, n= 3) 258F 25 103F 8 284F 25 110F 10 117F 4
Transition from normosmotic
to hyposmotic, n= 7
287F 17 119F 7 189F 17* 10F 7* 9F 3*
Transition from hyperosmotic
(33 mM Me-GPD) to
normosmotic, n= 3
270F 3 106F 11 308F 53 120F 13 129F 31
PRP before any interventions was set as 100%.
In the control group, treatment corresponds to Rb+ washout under isosmotic conditions (KHB).
* Statistically different vs. control.
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volume regulation in newborn rat and adult rabbit cardio-
myocytes [9,10]. DMA inhibition of the Rb+/K+ efflux in
the second model (Table 1) could be explained by the
functional coupling between the putative nonselective cat-
ion/H+ exchanger and the Na+/H+ exchanger. Indeed, pro-
tons transferred into the cytoplasm by the nonselective
cation/H+ exchanger can be removed to the interstitium by
the Na+/H+ exchanger. This coupling would be expected to
facilitate the K+ efflux through the K+/H+ exchanger.
Inhibition of the Na+/H+ exchanger by DMA would also
inhibit the K+/H+ exchange through the cytoplasmic H+
accumulation. However, the DMA effect was not mediated
by the Na+/H+ exchanger because transient intracellular
acidosis induced by the hyposmotic shock was not enhanced
by DMA treatment (Fig. 6). It is worth to note that, under
low [Na+] conditions, in guinea pig hearts, a decrease in the
osmolarity of the perfusion buffer was also accompanied by
a moderate acidosis of 0.04 unit, and, conversely, hyper-
osmotic perfusion caused an alkalosis, which was not
mediated by the Na+/H+ exchanger [35].
We suggest that DMA directly inhibits the nonselective
cation/H+ exchanger. A non-selective cation/proton anti-
porter was identified in sarcolemmal vesicles from bovine
hearts [13,14]. This antiporter has been demonstrated to
exchange Na+, K+, or Rb+ for H+ in an amiloride-sensitive
manner [13]. Furthermore, we have recently reported that
moderate alkalosis (0.2 units) significantly activated the Rb+
efflux from perfused rat hearts [15]. This suggested activa-
tion of a cation/H+ exchanger or a cation/OH co-trans-
porter. The K+/H+ exchanger was characterized in bacteria,
Amphiuma red blood cells, corneal epithelium, rat ileum,
rabbit gastric glands, and mammalian mitochondria
[6,23,36–39]. In Amphiuma red blood cells, the K+/H+
exchanger has been shown functionally coupled to Cl/
HCO3
 exchanger [36], whereby acid equivalents brought
by the K+/H+ exchanger are neutralized by HCO3
 influx. In
rat hearts, we could detect some coupling between these two
systems. Indeed, an inhibitor of the Cl/HCO3
 exchanger,
DNDS, inhibited the Rb+ efflux. In addition, intracellular
acidosis induced by hyposmotic swelling was prolonged by
DNDS. An additional mechanism may include stretch-
activated cation channels that were also described in neo-
natal rat atrial cells and adult rabbit ventricular myocytes
[40,41].
4.3. Contribution of hyposmotic shock to the Rb+/K+ efflux
after ischemia
An increase in the Rb+/K+ efflux after ischemia was
partially Glib-sensitive due to the activation of KATP chan-
nels by energy deprivation [16]. We hypothesized initially
that an increase in intracellular osmolarity of ischemic hearts
contributed to the reperfusion-induced stimulation of the
Rb+/K+ efflux. Therefore, reperfusion of the hearts with a
higher osmolarity buffer was expected to decrease the rate
of the Rb+ efflux. However, the stimulation was not
inhibited by hyperosmotic reperfusion. In fact, the rate of
the Rb+/K+ efflux was even higher in the hearts perfused
under hyperosmotic conditions. It is not impossible that 20-
min ischemia damages the sarcolemma of the cardiomyo-
cytes irreversibly, and Rb+ or K+ passively leaks out of the
cells on reperfusion. Twelve-minute ischemia does not result
in a considerable damage to the cardiomyocytes, judging by
almost complete recovery of contractile function on reper-
fusion. Yet, the effects of the 12-min ischemia, which
produces reversible damage, were quantitatively similar to
those of the 20-min ischemia.
The effects of osmotic load on the outcome of ischemic
injury were assessed using 31P-NMR in guinea pig hearts by
Befroy et al. [35]. The group found that while osmotic
shocks, per se, were not deleterious, recovery of the hyper-
osmotic hearts after ischemia was significantly compro-
mised in comparison to the controls [35]. One possibility,
they suggested, was that hyperosmotic perfusion before
ischemia added to the osmolar load during ischemia. How-
ever, we have demonstrated that even when hearts were
normosmotic before the onset of ischemia, hyperosmotic
reperfusion actually increases the Rb+/K+ efflux. It seems
that cell swelling does not significantly contribute to the
reperfusion-activated Rb+ efflux in crystalloid-perfused iso-
volumic rat hearts. There are several plausible explanations
for this. First, ischemia can interrupt signal transduction,
which normally results in activation of ion transporters by
swelling. Second, contrary to the above, protein kinases and
ion transporters could be already activated by ischemia and
hence cell swelling during reperfusion could not further
activate them. Third, intracellular acidosis, which is main-
tained during the first minutes of reperfusion, could inhibit
the putative cation/H+ exchanger. Fourth, Langendorff-per-
fused hearts are not completely identical to the working
blood-perfused hearts or hearts in vivo, and some critical
factors, such as, for example, neurohumoral regulation, are
missing.
5. Conclusions
In this study we have demonstrated that osmotic swelling
stimulated unidirectional and net Rb+/K+ efflux from myo-
cytes in the intact Langendorff-perfused rat heart under
normal metabolic conditions. The stimulation of the Rb+/
K+ efflux occurred, at least partially, through the DMA-
sensitive cation/H+ exchanger. Post-ischemic reperfusion
also activated Rb+ efflux; however, swelling-induced mech-
anisms did not contribute considerably to this activation.
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